zorbax extended-c18 rapid column (Agilent technologies)
90
Structured Review
Agilent technologies
zorbax extended-c18 rapid column
Zorbax Extended C18 Rapid Column, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/extend+c18/pmc11385525-385-13-18
Average 90 stars, based on 1 article reviews
Zorbax Extended C18 Rapid Column, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/extend+c18/pmc11385525-385-13-18
Average 90 stars, based on 1 article reviews
zorbax extended-c18 rapid column - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Antioxidant Activity In Vitro Guided Screening and Identification of Flavonoids Antioxidants in the Extract from Tetrastigma hemsleyanum Diels et Gilg Article Snippet: The chromatographic separation was conducted using a Article Title: Establishment of a Method for the Detection of Indaziflam, Spirotetramat, Cyantraniliprole, and Their Metabolites and Application for Fruit and Vegetable Risk Assessment. Article Snippet: The presence of pesticides in foodstuffs has received increasing amount of attention worldwide.. In this study, an efficient and sensitive QuEChERS/HPLC-MS/MS-based method was established for the simultaneous detection of indaziflam, cyantraniliprole, spirotetramat, and their metabolites on fruits and vegetables.. The purification procedure and detection condition parameters were optimized. Article Title: Qingre Huoxue Decoction regulates macrophage polarisation to attenuate atherosclerosis through the inhibition of NF-κB signalling-mediated inflammation. Article Snippet: Ethnopharmacological relevance: Atherosclerosis (AS) is a common pathogenesis of cardiovascular diseases.. Qingre Huoxue Decoction (QRHX) is an herbal formula used for the prevention and treatment of AS.. However, the potential mechanism of QRHX is not clear. High Performance Liquid Chromatography:Article Title: Mass balance study of [ 14 C]SHR0302, a selective and potent JAK1 inhibitor in humans. Article Snippet: SHR0302, a selective JAK1 inhibitor developed by Jiangsu Hengrui Pharmaceutical Co., was intended for the treatment of rheumatoid arthritis.. In this study, we evaluated the pharmacokinetics, mass balance, and metabolism of SHR0302 in six healthy Chinese male subjects after a single 8mg (80 mCi) oral dose of [C]SHR0302.. SHR0302 was absorbed rapidly (Tmax 1⁄4 0.505 h), and the average t1/2 of the SHR0302-related components in plasma was approximately 9.18 h. After an oral dose was administered, the average cumulative excretion of the radioactive components was 100.56% ± 1.51%, including 60.95% ± 11.62% in urine and 39.61% ± 10.52% in faeces. |